DE69614571T2 - Verfahren zur herstellung von lovastatin - Google Patents

Verfahren zur herstellung von lovastatin

Info

Publication number
DE69614571T2
DE69614571T2 DE69614571T DE69614571T DE69614571T2 DE 69614571 T2 DE69614571 T2 DE 69614571T2 DE 69614571 T DE69614571 T DE 69614571T DE 69614571 T DE69614571 T DE 69614571T DE 69614571 T2 DE69614571 T2 DE 69614571T2
Authority
DE
Germany
Prior art keywords
producing lovastatin
lovastatin
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69614571T
Other languages
English (en)
Other versions
DE69614571D1 (de
Inventor
Dimcho Ivanov Dimov
Georgy Asenov Grozdanov
Nedelcho Genov Petkov
Dimitra Tsoneva Todorova
Albena Stefanova Dimitrova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BalkanPharma Razgrad AD
Original Assignee
BalkanPharma Razgrad AD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BG100197A external-priority patent/BG62651B1/bg
Priority claimed from BG100316A external-priority patent/BG63011B1/bg
Application filed by BalkanPharma Razgrad AD filed Critical BalkanPharma Razgrad AD
Application granted granted Critical
Publication of DE69614571D1 publication Critical patent/DE69614571D1/de
Publication of DE69614571T2 publication Critical patent/DE69614571T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69614571T 1995-12-06 1996-10-22 Verfahren zur herstellung von lovastatin Expired - Fee Related DE69614571T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BG100197A BG62651B1 (bg) 1995-12-06 1995-12-06 Метод за изолиране и пречистване на ловастатин
BG100316A BG63011B1 (bg) 1996-01-29 1996-01-29 метод за получаване на ловастатин
PCT/BG1996/000013 WO1997020834A1 (en) 1995-12-06 1996-10-22 Method of production of lovastatin

Publications (2)

Publication Number Publication Date
DE69614571D1 DE69614571D1 (de) 2001-09-20
DE69614571T2 true DE69614571T2 (de) 2002-06-27

Family

ID=25663364

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69614571T Expired - Fee Related DE69614571T2 (de) 1995-12-06 1996-10-22 Verfahren zur herstellung von lovastatin
DE0877742T Pending DE877742T1 (de) 1995-12-06 1996-10-22 Verfahren zur herstellung von lovastatin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0877742T Pending DE877742T1 (de) 1995-12-06 1996-10-22 Verfahren zur herstellung von lovastatin

Country Status (8)

Country Link
EP (1) EP0877742B1 (de)
AU (1) AU7271696A (de)
CA (1) CA2243592C (de)
DE (2) DE69614571T2 (de)
EA (1) EA000954B1 (de)
ES (1) ES2131037T3 (de)
UA (1) UA44922C2 (de)
WO (1) WO1997020834A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9800046A (sl) * 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
EP1055671B1 (de) * 1998-12-10 2004-12-01 Kaneka Corporation Verfahren zur herstellung eines simvastatin precursors
SK282679B6 (sk) * 1999-04-16 2002-11-06 Biotika, A. S. Spôsob izolácie lovastatínu z vyfermentovanej pôdy
DE01913139T1 (de) * 2000-03-03 2005-03-31 Plus Chemical S.A. Ein verfahren zur reinigung von lovastatin und simvastatin mit verringertem gehalt an dimeren verunreinigungen
IN192861B (de) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
ES2204285B1 (es) * 2002-05-20 2005-03-01 Ercros Industrial, S.A. Procedimiento para el aislamiento y purificacion de lovastatina.
CA2540068C (en) 2003-10-14 2012-05-29 Lupin Limited A method for the manufacture of lovastatin
BRPI0418644A (pt) 2004-03-30 2007-05-29 Lupin Ltd processo para a preparação de um composto
WO2009013764A2 (en) * 2007-07-24 2009-01-29 Jubilant Organosys Limited Process for producing 6(r)-[2-(8'(s)-2 ',2 '-dimethylbutyryloxy-2'(s),6'(r)-dimethyl-1,2,6,7', 8',8a'(r)- hexahydronaphthyl-l'(s))ethyl]-4(r)-hydroxy-3,4,5,6- tetrahydro-2h-pyran-2-one
CN103012344B (zh) * 2011-09-28 2014-11-12 北大方正集团有限公司 从洛伐他汀结晶母液中回收洛伐他汀的方法
EP2597092A1 (de) 2011-11-24 2013-05-29 Sterling Biotech Limited Verfahren zum Reinigen von Lovastatin
CN102875505B (zh) * 2012-08-02 2015-08-05 丽珠集团新北江制药股份有限公司 一种美伐他汀的提取精制工艺
CN106083789A (zh) * 2016-06-07 2016-11-09 山东鲁抗医药股份有限公司 从发酵液中沉淀分离提取洛伐他汀的方法
CN108976190B (zh) * 2017-12-21 2020-09-04 北大方正集团有限公司 一种从洛伐他汀结晶母液中回收洛伐他汀的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance

Also Published As

Publication number Publication date
CA2243592A1 (en) 1997-06-12
UA44922C2 (uk) 2002-03-15
WO1997020834A1 (en) 1997-06-12
ES2131037T1 (es) 1999-07-16
EP0877742B1 (de) 2001-08-16
ES2131037T3 (es) 2001-12-16
AU7271696A (en) 1997-06-27
EP0877742A1 (de) 1998-11-18
EA000954B1 (ru) 2000-08-28
EA199800522A1 (ru) 1999-02-25
DE69614571D1 (de) 2001-09-20
CA2243592C (en) 2001-12-25
DE877742T1 (de) 1999-07-22

Similar Documents

Publication Publication Date Title
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE59604922D1 (de) Verfahren zur herstellung von polyalkoholen
DE69604277T2 (de) Verfahren zur herstellung von nootkaton
DE69618646T2 (de) Verfahren zur herstellung von peroxiden
DE69613486D1 (de) Verbessertes verfahren zur herstellung von bisphenolen
DE69628421D1 (de) Verfahren zur herstellung von tetraazacycloalkanen.
DE69511290T2 (de) Verfahren zur herstellung von halohydroxypropyltrialkylammoniumhalogeniden
ATE187727T1 (de) Verfahren zur herstellung von imidazo- benzodiazepin-derivaten
DE59601604D1 (de) Verfahren zur herstellung von n-aryl- und n-hetarylhydroxylaminen
ATE229021T1 (de) Verfahren zur herstellung von imidazochinazolinon-derivaten
DE69614571T2 (de) Verfahren zur herstellung von lovastatin
ATE240300T1 (de) Verfahren zur herstellung von phenylimidazolin- derivaten
ATE309230T1 (de) Verfahren zur herstellung von 2- chlorthiazolderivaten
DE59601895D1 (de) Verfahren zur herstellung von butyrolactonen
DE69616322D1 (de) Verfahren zur herstellung von 3-isochromanonen
DE69601993T2 (de) Verfahren zur herstellung von doxorubicin
DE69625466T2 (de) Verfahren zur herstellung von polyethylennaphathalat
DE69615836T2 (de) Verfahren zur herstellung von boroxyd
DE69611380D1 (de) Verfahren zur herstellung von dioxoazabiclohexanderivaten
DE69615011T2 (de) Verfahren zur herstellung von tetrafluorethylen
DE69608811T2 (de) Verfahren zur herstellung von heptafluorpropan
DE69609499T2 (de) Verfahren zur herstellung von streptograminen
ATE196146T1 (de) Verfahren zur herstellung von ivermectin
DE59605764D1 (de) Verfahren zur herstellung von 2-trifluormethoxy-benzolsulfonamid
ATE188213T1 (de) Verfahren zur herstellung von 3-hydroxyoxetanen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee